Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards Contract to Global BioClinical to Support Cancer Genome Atlas

NEW YORK (GenomeWeb News) – Global BioClinical said on Tuesday that the National Cancer Institute has awarded it a contract to set up and manage a research biospecimen collection network of cancer treatment centers in support of the Cancer Genome Atlas project.

The centers established by Global BioClinical will enroll patients who have been diagnosed with various cancers and who are scheduled for surgical treatment. Participants will donate biospecimens, such as pre-surgical blood samples and resected surplus surgical tissues. The specimens along with de-identified medical and pathological information will then go to TCGA-affiliated laboratories for analysis.

Collected biospecimens must meet certain criteria so that extracted DNA and RNA can be used for advanced genomic analysis and sequencing technologies, Global BioClinical said. TCGA aims to examine up to 500 biospecimens for each tumor type to produce a comprehensive genomic profile for every cancer type and data that can be used to identify the best targets for the development of new cancer therapeutics.

Global BioClinical did not disclose the terms of its contract. Based in Seattle, the firm provides contract consulting and CRO services. It said it has expertise in organizational and project management, clinical trial planning and execution, and human biospecimens.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.